Rammensee HG - Search Results

1

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia.

Nelde A, Maringer Y, Bilich T, Salih HR, Roerden M, Heitmann JS, Marcu A, Bauer J, Neidert MC, Denzlinger C, Illerhaus G, Aulitzky WE, Rammensee HG, Walz JS. Nelde A, et al. Among authors: rammensee hg. Front Immunol. 2021 Jul 8;12:705974. doi: 10.3389/fimmu.2021.705974. eCollection 2021. Front Immunol. 2021. PMID: 34305947 Free PMC article. Clinical Trial.

2

Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach.

Schirle M, Keilholz W, Weber B, Gouttefangeas C, Dumrese T, Becker HD, Stevanović S, Rammensee HG. Schirle M, et al. Among authors: rammensee hg. Eur J Immunol. 2000 Aug;30(8):2216-25. doi: 10.1002/1521-4141(2000)30:8<2216::AID-IMMU2216>3.0.CO;2-7. Eur J Immunol. 2000. PMID: 10940913 Free article.

3

Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.

Salih HR, Rammensee HG, Steinle A. Salih HR, et al. Among authors: rammensee hg. J Immunol. 2002 Oct 15;169(8):4098-102. doi: 10.4049/jimmunol.169.8.4098. J Immunol. 2002. PMID: 12370336

4

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

Weinschenk T, Gouttefangeas C, Schirle M, Obermayr F, Walter S, Schoor O, Kurek R, Loeser W, Bichler KH, Wernet D, Stevanović S, Rammensee HG. Weinschenk T, et al. Among authors: rammensee hg. Cancer Res. 2002 Oct 15;62(20):5818-27. Cancer Res. 2002. PMID: 12384544

5

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.

Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG, Steinle A. Salih HR, et al. Among authors: rammensee hg. Blood. 2003 Aug 15;102(4):1389-96. doi: 10.1182/blood-2003-01-0019. Epub 2003 Apr 24. Blood. 2003. PMID: 12714493 Free article.

6

The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.

Singh-Jasuja H, Emmerich NP, Rammensee HG. Singh-Jasuja H, et al. Among authors: rammensee hg. Cancer Immunol Immunother. 2004 Mar;53(3):187-95. doi: 10.1007/s00262-003-0480-x. Epub 2004 Jan 31. Cancer Immunol Immunother. 2004. PMID: 14758508 Free PMC article. Review.

7

Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.

Radsak MP, Salih HR, Rammensee HG, Schild H. Radsak MP, et al. Among authors: rammensee hg. J Immunol. 2004 Apr 15;172(8):4956-63. doi: 10.4049/jimmunol.172.8.4956. J Immunol. 2004. PMID: 15067076

8

Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry.

Dengjel J, Decker P, Schoor O, Altenberend F, Weinschenk T, Rammensee HG, Stevanovic S. Dengjel J, et al. Among authors: rammensee hg. Eur J Immunol. 2004 Dec;34(12):3644-51. doi: 10.1002/eji.200425510. Eur J Immunol. 2004. PMID: 15495271 Free article.

9

Immunotherapy of renal cell carcinoma.

Gouttefangeas C, Stenzl A, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Among authors: rammensee hg. Cancer Immunol Immunother. 2007 Jan;56(1):117-28. doi: 10.1007/s00262-006-0172-4. Epub 2006 May 5. Cancer Immunol Immunother. 2007. PMID: 16676181 Free PMC article. Review.

10

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR. Kloss M, et al. Among authors: rammensee hg. J Immunol. 2008 Nov 15;181(10):6711-9. doi: 10.4049/jimmunol.181.10.6711. J Immunol. 2008. PMID: 18981088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters